Equities

Shanghai ZJ Bio-Tech Co Ltd

688317:SHH

Shanghai ZJ Bio-Tech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)14.20
  • Today's Change-4.06 / -22.23%
  • Shares traded1.47m
  • 1 Year change-38.79%
  • Beta0.8882
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai ZJ Bio-Tech Co Ltd is a China-based company that mainly engaged in the production of molecular diagnostic reagents. The Company is mainly engaged in the research, development, production and sales of genetic diagnostic reagents and equipment. The Company's main products include nucleic acid detection kits and molecular diagnostic instruments. The Company's products are mainly used in areas such as emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The Company mainly conducts business within the domestic market.

  • Revenue in CNY (TTM)206.71m
  • Net income in CNY-184.51m
  • Incorporated2005
  • Employees305.00
  • Location
    Shanghai ZJ Bio-Tech Co LtdBuilding 26No.588 Xinjun Ring Road, Pujiang Hi-TechPark, Caohejing Development ZoneSHANGHAI ChinaCHN
  • Phone+86 2 134680598
  • Fax+86 2 134680010
  • Websitehttps://www.liferiver.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Succeeder Technology Inc297.74m112.75m3.03bn296.0026.951.85--10.181.061.062.8015.410.17662.518.661,005,870.006.697.777.028.2560.3961.0337.8538.3414.78--0.0000422.2220.406.6012.2915.5799.03--
Cowealth Medical China Co Ltd970.41m29.67m3.04bn240.00102.392.60--3.130.07450.07452.442.930.64353.901.254,043,355.002.015.802.598.0919.6220.743.136.143.65--0.082923.89-14.623.85-42.96-6.7532.85--
Hangzhou Biotest Biotech Co Ltd518.65m104.29m3.21bn629.0030.401.35--6.190.98970.98974.9422.270.2042.616.85824,563.604.0129.454.2333.3052.4256.8319.6441.5912.53--0.000329.32-76.7519.65-86.2241.3334.82--
Shanghai Kindly Enterprise Dev Gp Co Ltd2.28bn209.26m3.40bn4.23k16.061.36--1.490.47960.47965.245.680.55853.892.41540,095.705.798.099.2716.0930.4536.0110.3712.531.25--0.193126.55-21.3611.08-25.929.444.851.30
Shanghai General Hthy Info & Tech Co Ltd261.57m18.00m3.40bn355.00188.933.18--13.000.13240.13241.927.880.19081.160.5944736,806.401.0311.221.3214.1361.9553.645.4230.542.58--0.121614.00-4.593.70-48.13-4.279.32--
Shanghai ZJ Bio-Tech Co Ltd206.71m-184.51m3.51bn305.00--0.9299--16.97-1.03-1.031.1119.640.05070.18932.00677,741.90-4.5217.08-4.7419.1868.9260.21-89.2634.1318.50--0.001434.15-88.214.10-118.00--35.93--
Jinan High-tech Development Co Ltd481.47m-85.16m3.63bn716.00--20.63--7.53-0.0963-0.09630.54430.19870.17540.56950.5716672,442.60-4.12-2.99-22.80-9.4216.0130.52-23.48-10.840.5515-18.560.4291---58.29-13.80-618.17---35.45--
Chimin Health Management Co Ltd899.55m-82.14m3.90bn1.95k--2.54--4.33-0.1882-0.18821.742.930.35623.934.91462,018.90-3.051.54-3.902.4140.5644.32-8.584.051.24-3.660.245429.556.845.09-289.97---10.57--
Data as of Sep 13 2024. Currency figures normalised to Shanghai ZJ Bio-Tech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.89%Per cent of shares held by top holders
HolderShares% Held
Rongtong Fund Management Co., Ltd.as of 30 Jun 20243.41m2.76%
GF Fund Management Co., Ltd.as of 30 Jun 20242.30m1.86%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024906.50k0.73%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024368.30k0.30%
E Fund Management Co., Ltd.as of 30 Jun 2024125.35k0.10%
China Fund Management Co., Ltd.as of 30 Jun 202456.47k0.05%
Tian Hong Asset Management Co., Ltd.as of 30 Jun 202433.20k0.03%
China Merchants Fund Management Co., Ltd.as of 30 Jun 202430.32k0.03%
Penghua Fund Management Co., Ltd.as of 30 Jun 202428.27k0.02%
Nuode Asset Management Co., Ltd.as of 30 Jun 202427.11k0.02%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.